FDA Issues 3p510K Guidance
On November 21, 2024, the US Food and Drug Administration (FDA) published its final guidance for manufacturers seeking to authorize low-to-medium risk devices through the Third Party 510K (3P510K) Review Program. The program uses qualified third parties to conduct initial reviews of 510K device submissions. The FDA’s guidance also describes the use of third party review organizations for Emergency Use Authorization (EUA) requests.